CWM
LLY icon

Compass Wealth Management’s Eli Lilly LLY Stock Holding History

Compass Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,203
Closed -$4.73M – 118
2025
Q3 		$4.73M Buy
6,203
+75
+1% +$55.8K 1.06% 33
2025
Q2 		$4.78M Hold
6,128
– – 1.14% 33
2025
Q1 		$5.06M Sell
6,128
-502
-8% -$418K 1.29% 24
2024
Q4 		$5.12M Sell
6,630
-110
-2% -$91.1K 1.23% 24
2024
Q3 		$5.97M Sell
6,740
-440
-6% -$396K 1.41% 21
2024
Q2 		$6.5M Sell
7,180
-125
-2% -$100K 1.6% 11
2024
Q1 		$5.68M Sell
7,305
-420
-5% -$299K 1.42% 17
2023
Q4 		$4.5M Sell
7,725
-345
-4% -$201K 1.26% 24
2023
Q3 		$4.33M Sell
8,070
-630
-7% -$325K 1.36% 19
2023
Q2 		$4.08M Sell
8,700
-125
-1% -$52.4K 1.23% 28
2023
Q1 		$3.03M Sell
8,825
-261
-3% -$88K 0.96% 38
2022
Q4 		$3.32M Buy
+9,086
New +$3.22M 1.09% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Compass Wealth Management's LLY Position: Q4 2025 in Review

Compass Wealth Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 6,203 shares — an estimated $4.73M sold.

Compass Wealth Management first reported a position in LLY in Q4 2022 and held it in 12 quarters. The position peaked at $6.5M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Compass Wealth Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 6,203 Eli Lilly shares in Q4 2025, an estimated $4.73M.
  • Compass Wealth Management first reported a position in Eli Lilly in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Eli Lilly position peaked at $6.5M in Q2 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.